| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| drotaverine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| drotaverine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| drotaverine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| drotaverine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| drotaverine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| drotaverine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| drotaverine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| drotaverine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| drotaverine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| drotaverine | camp-specific 3',5'-cyclic phosphodiesterase 4a | small molecule | NA | drugbank | Cholecystitis[MeSHID:D002764] Smooth muscle (tissue)[MeSHID:D009130] Gall Bladder Diseases[MeSHID:D005705] Spasm[MeSHID:D013035] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||